*ST左江(300799) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥11,624,030.64, a decrease of 60.91% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥21,297,869.14, representing a decline of 539.95% year-on-year[5]. - The basic earnings per share for the period was -¥0.2088, down 535.91% from the previous year[5]. - Total operating revenue for Q3 2022 was ¥37,279,144.24, a decrease of 63.2% compared to ¥100,873,319.32 in the same period last year[20]. - Net profit for Q3 2022 was a loss of ¥90,310,481.16, compared to a profit of ¥19,639,673.90 in Q3 2021, representing a significant decline[21]. - The company reported a total comprehensive loss of ¥90,310,481.16 for the quarter, contrasting with a comprehensive income of ¥19,639,673.90 in Q3 2021[21]. Assets and Liabilities - Total assets at the end of the reporting period were ¥749,147,764.09, a decrease of 5.77% from the end of the previous year[5]. - The company's total liabilities decreased to ¥63,413,686.78 from ¥70,518,692.46, a reduction of 10.0%[20]. - The equity attributable to shareholders of the parent company fell to ¥671,239,137.94, down 6.0% from ¥713,661,811.64[20]. - Total assets decreased from ¥795,038,344.12 at the beginning of the year to ¥749,147,764.09, a decline of about 5.77%[17]. Cash Flow - The cash flow from operating activities for the first nine months was -¥154,488,514.65, an increase in negative cash flow of 453.38% compared to the same period last year[11]. - The net cash flow from operating activities for the period was -154,488,514.65 CNY, compared to -27,917,015.94 CNY in the previous period, indicating a significant decline[22]. - Total cash inflow from operating activities was 25,945,501.91 CNY, down 83.1% from 153,893,757.43 CNY year-over-year[22]. - Cash outflow from operating activities totaled 180,434,016.56 CNY, slightly decreased from 181,810,773.37 CNY in the previous period[22]. - The ending cash and cash equivalents balance was 121,022,191.38 CNY, down from 289,175,982.77 CNY in the previous period[23]. Investment and R&D - Research and development expenses increased by 77.95% to ¥80,849,911.28, reflecting the company's commitment to enhancing R&D projects[9]. - The company is currently constructing a R&D manufacturing center in Chengdu, which has contributed to a 93.95% increase in construction in progress[9]. - The company experienced a 528.67% increase in cash outflow from investment activities, primarily due to expenditures related to the Chengdu R&D center[11]. - Research and development expenses surged to ¥80,849,911.28, an increase of 77.9% from ¥45,434,211.45 in the previous year[20]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 6,546[13]. - The largest shareholder, Zhang Jun, holds 23.10% of shares, totaling 23,577,300 shares[13]. - The company has a significant concentration of ownership, with the top four shareholders being Zhang Jun, He Chaohui, Zhang Yinan, and He Peixian, all acting in concert[14]. - The company reported a total of 755,754 shares held by Hu Bo, with no restrictions on sale[14]. Operational Challenges - The company reported a significant decrease in operating income, which was affected by the COVID-19 pandemic and product transition cycles, down 63.04% year-on-year[9]. - The company has not reported any new product developments or market expansion strategies in the current quarter[15]. - Future outlook and strategic initiatives were not explicitly mentioned in the provided content, suggesting a focus on recovery and stabilization[19]. - The company's cash flow situation indicates a need for strategic adjustments to improve operational efficiency and investment returns[24].